Source comparison
Administration Protocol: Injectable vs Oral Bioavailability
GHRP-2 Acetate requires reconstitution from lyophilised powder using bacteriostatic water, followed by subcutaneous injection at precise intervals. Standard research protocols administer 100–300 mcg per dose, 2–3 times daily, with timing aligned to fasting win
This comparison does not assign a generated winner or score.
- GHRP-2 Acetate requires reconstitution from lyophilised powder using bacteriostatic water, followed by subcutaneous injection at precise intervals. Standard research protocols administer 100–300 mcg per dose, 2–3 times daily, with timing aligned to fasting windows to prevent interference from elevated glucose or insulin. Pre-meal administration (30 minutes before food intake) maximises GH response. Consuming carbohydrates within 60 minutes of injection blunts the GH pulse by up to 50% due to insulin-mediated somatostatin release. Reconstituted GHRP-2 must be refrigerated at 2–8°C and used within 28 days to prevent peptide degradation.
- MK-677 is administered orally as a capsule or liquid suspension, with no reconstitution or injection required. Dosing once daily at 10–25mg produces consistent plasma levels regardless of meal timing, though some research groups administer it before bed to align GH elevation with natural nocturnal secretion patterns. The oral route eliminates injection-site reactions, needle disposal protocols, and the cold-chain storage complexity that complicates multi-site research studies. MK-677 powder is stable at room temperature for months when stored in airtight containers away from moisture.
- The administration burden matters in long-term protocols. A 12-week GHRP-2 study requires 168–252 injections depending on dosing frequency. MK-677 requires 84 oral doses. For research models involving extended timelines or large subject cohorts, the logistical difference is non-trivial. Our team has observed compliance drop-off in GHRP-2 protocols after week 6–8, attributed to injection fatigue rather than adverse effects.